46
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Contributions of Benzodiazepines to Cancer Therapy

, &
Pages 103-111 | Published online: 11 Jun 2009

References

  • Derogatis L R, Feldstein M, Morrow G, et al. A survey of psychotropic drug prescriptions in an oncology population. Cancer 1979; 44: 1919–1929
  • Goldberg R, Mor J. V. A survey of psychotropic use in terminal cancer patients. Psychosomatics 1985; 26: 745–751
  • Dundee J W, McGowan W A, Lilburn J, Mc K., Kay A C, Hegarty J E. Comparison of the actions of diazepam and lorazepam. Br J Anaesth 1979; 51: 439–445
  • Cohn J B. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam, and placebo in clinically anxious patients. J Clin Psychiatry 1981; 42: 347–351
  • Meyer B R. Benzodiazepines in the elderly. Med Clin North Am 1982; 66: 1017–1036
  • Wilson P G. Anxiety and depression in elderly and dying patients. Med Clin North Am 1982; 66: 1011–1016
  • Horrobin D F, Trosko J E. The possible effect of diazepam on cancer development and growth. Med Hypotheses 1981; 7: 115–125
  • Kaufman D W, Slone Shapiro D. S, et al. Diazepam and the risk of breast cancer. Lancet 1982; 1: 537–539
  • Weisman A D, Worden J W. The existential plight in cancer: significance of the first 100 days. Int J Psychiatry Med 1976; 77: 1–15
  • Fetting J H. Identifying and treating psychiatric disorders in cancer patients. Geriatrics 1982; 37: 95–105
  • Romsaas E P, Malec J, Javenkoski F., et al. Psychological distress among women with breast problems. Cancer 1986; 57: 890–895
  • Scott D W. Anxiety, critical thinking and information processing during and after breast biopsy. Nurs Res 1983; 32: 24–28
  • Levy M H, Catalano R B. Control of common physical symptoms other than pain in patients with terminal disease. Semin Oncol 1982; 12: 411–430
  • Rosenbaum J F. The treatment of anxiety. N Engl J Med 1982; 306: 401–404
  • Feighner J P, Aden G C, Fabre L F, et al. Comparison of alprazolam imipramine. and placebo in the treatment of depression. J Am Med Assoc 1983; 249: 3057–3064
  • Katz E R, Kellerman J, Siegel S E. Behavioural distress in children with cancer undergoing medical procedures: developmental considerations. J Consult Clin Psychol 1981; 68: 356–365
  • Seigel L J, Longo D L. The control of chemotherapy-induced emesis. Ann Intern Med 1981; 95: 352–359
  • Mellencamp E, Wang H. The patient with nausea III. Cancer, pregnancy, or surgery. Drug Ther (June) 1977; 102–111
  • Petro D (1985) Status of current clinical studies. Proceedings of an Investigational Review - June 10. 1983 - Lorazepam as an Adjunct in Cancer Chemotherapy. June 10, 1983, J Laszlo. Oncol Times, 7: 11–12, (suppl)
  • Bowcock S J, Stockdale A D, Bolton J AR, et al. Antiemetic prophylaxis with high dose metoclopramide or lorazepam in vomiting induced by chemotherapy. Br Med J 1984; 288: 1879, (letter)
  • Laszlo J, Clark R A, Hanson D C, et al. Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic and anxiolytic effects. J Clin Oncol 1985; 8: 864–869
  • Bishop J F, Olver I N, Wolf M M, et al. Lorazepam: a randomized double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine. J Clin Oncol 1984; 2: 691–695
  • Maher J. Intravenous lorazepam to prevent nausea and vomiting associated with cancer chemotherapy. Lancet 1981; 1: 91–9, (letter)
  • Gagen M, Gochnour Young D. D, et al. A randomized trial of metoclopramide and a combination of dexamethansone and lorazepam for prevention of chemotherapy-induced vomiting. J Clin Oncol 1984; 2: 696–701
  • Semrad N, Leuchter F. RS, Townsend D E, et al. A pilot study of lorazepam-induced amnesia with cis-platinum-containing chemotherapy. Gynecol Oncol 1984; 17: 277–280
  • Natale R B (1985) Current evaluation of efficacy: the University of Michigan experience. Proceedings of an Investigational Review - June 10. 1983 - Lorazepam as an Adjunct in Cancer Chemotherapy. June 10, 1983, J Laszlo. Oncol Times, 7: 13–14, (suppl)
  • Robins H I, Ershler W, De B., Jough L, et al. Antiemetic effect of intravenous diazepam in patients receiving cis-diamminedi-chloroplatinum - a pilot study. Med Pediatr Oncol 1979; 7: 247–249
  • Plezia P M, Alberts D, Kessler S. J, et al. Immediate termination of intractable vomiting induced by cisplatin combination chemotherapy using an intensive five drug antiemetic regimen. Cancer Treat Rep 1984; 68: 1693–1695
  • Luesley D M, Terry P B, Chan K K. High-dose intravenous metoclopramide and intermittent intramuscular prochlorperazine and diazepam in the management of emesis induced by cis-dichiorodiammineplatinum. Cancer Chemother Pharmacol 1985; 14: 250–252
  • Matilla M AK, Rajpar M P, Pytynen P. Diazepam as an adjuvant in propanediol anesthesia for abortion. Br J Anesthesiol 1974; 46: 446–448
  • Peroutka S J, Synder S H. Antiemeticsneurotransmitter receptor binding predicts therapeutic actions. Lancet 1982; 1: 658–659
  • Laszlo J. Current evaluation of efficacy: The Duke University experience. In: Proceedings of an Investigational Review - June 10, 1983 - Lorazepam as an Adjunct in Cancer Chemotherapy. J Laszlo. Oncol Times 1985; 7(suppl)15–17
  • Wilcox P M, Fetting J H, Nettesheim K M, Abeloff M D. Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma. Cancer Treat Rep 1982; 66: 1601–1604
  • Morrow G R, Arseneau J, Asbury C. RF, et al. Anticipatory nausea and vomiting in chemotherapy patients. N Engl J Med 1982; 306: 431–432
  • Redd W H, Andrykowski M A. Behavioral intervention in cancer treatment: controlling aversion reactions to chemotherapy-V. Consult Clin Psychol 1982; 50: 1018–1029
  • Neese R M, Carli T, Curtis G C, Kleinman P D. Pretreatment nausea in cancer chemotherapy: a conditioned response. Psychosomatic Med 1980; 42: 33–36
  • Leuchter R S. Current evaluation of efficacy: The UCLA-Cedars-Sinai Medical Center experience. In: Proceedings of an Investigational Review - June 10, 1983 - Lorazepam as an Adjunct in Cancer Chemotherapy, J Laszlo. Oncol Times 1985; 7(suppl)21–23
  • Nerenz D R, Leventhal H, Easterling D V, Love R R. Anxiety and drug taste as predictors of anticipatory nausea in cancer chemotherapy. J Clin Oncol 1986; 4: 224–233
  • Spence K W. Anxiety (drive) level and performance in eyelid conditioning. Psychol Bull 1966; 61: 129–139
  • Altmaier E M, Ross W E, Moore K A. A pilot investigation of the psychologic functioning of patients with anticipatory vomiting. Cancer 1982; 49: 201–204
  • Eysenck H J, Beech H R. Counterconditioning and related methods in behaviour therapy. Handbook of Psychotherapy and Behavior Change, A E Bergin, S L Garfield. John Wiley, New York 1971; 536–611
  • Twycross R G, Lack S A. Symptom Control in Far Advanced Cancer: Pain Relief. Pitman Publ. Ltd., London 1983
  • Singh P, Sharma N. P, Gupta P, Pandeg K. K. Clinical evaluation of diazepam for relief of postoperative pain. Br J Anaesth 1981; 53: 831–836
  • Yosselson-Superstine S., Lipman A G, Sanders S H. Adjunctive antianxiety agents in the management of chronic pain. Isr J Med Sci 1985; 21: 113–117

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.